Abstract:Using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA), three dimensional structure-activity relationship (3D-QSAR) has been studied on a series of novel triazole antifungal compounds. For the CoMFA study, two different pharmacophoric conformations were compared and conformation generated from our previous homologous enzyme-inhibitor docking model got better results. Variation of grid spacing was used during the optimization of the CoMFA model. For the CoMSIA study, the influence of the combination of different field types was evaluated and the best combination was considered to be of steric, electrostatic, hydrophobic and H-bonding acceptor fields. Variation of grid spacing and attenuation factor was used to get the best CoMSIA model. The resulting CoMFA and CoMSIA models had a cross validated coeffiecient q(2) of 0.718 and 0.655 respectively, which showed strong predictive ability on both test set and training set. The 3D contour maps of CoMFA and CoMSIA provided smooth and interpretable explanation of the structure-antifungal activity relationship for the compounds. The analysis of the 3D contour plots permitted interesting conclusions about the effects of different substituent groups at different position of the phenyl group on the antifungal activity, which will guide the design of novel antifungal compounds with relatively high activity.

3 D-QSAR study on antimicrobial peptides by CoMFA method

Insight into the Structural Requirements of Antimicrobial Peptides by Multiple Validated 3D-QSAR Approaches

CoMFA and CoMSIA analysis of ACE-inhibitory, antimicrobial and bitter-tasting peptides.

Comprehensive Comparison of Twenty Structural Characterization Scales Applied As Qsam of Antimicrobial Dodecapeptides Derived from Bac2a Against P-Aeruginosa

In Silico Design of Antimicrobial Oligopeptides Based on 3D-QSAR Modeling and Bioassay Evaluation

QSAR modeling and design of cationic antimicrobial peptides based on structural properties of amino acids.

3D-QSAR Analysis on N-Phenylacetanoyl-L-Homoserine Lactones As Inhibitors of Bacterial Quorum Sensing Via CoMFA Approach

Hybrid 2D/3D-quantitative structure–activity relationship studies on the bioactivities and molecular mechanism of antibacterial peptides

Exploring 3D-QSAR for Ketolide Derivatives As Antibacterial Agents Using CoMFA and CoMSIA

3D-QSAR study of a series of novel triazole antifungal compounds

Three Dimensional Quantitative Structure-Activity Relationships of Sulfonamides Binding Monoclonal Antibody by Comparative Molecular Field Analysis

Primary Structural Characterizations of Polypeptide and Antimicrobial Peptides Qsam Modeling

3D-QSAR Studies on Tripeptide Aldehyde Inhibitors of Proteasome Using CoMFA and CoMSIA Methods

3D-QSAR study on a series of Bcl-2 protein inhibitors using comparative molecular field analysis.

Studies on Three-Dimensional Qsar of Muscarinic Receptor Agonists

Progress on CoMFA Research

3D-QSAR Study of AHMA Derivatives as Potent Anticancer Agents

Three-dimensional quantitative structure–activity relationship study for analogues of TQXs using CoMFA and CoMSIA

Studies of 3D-quantitative structure-activity relationships on a set of nitroaromatic compounds: CoMFA, advanced CoMFA and CoMSIA.

Three-dimensional quantitative structure-activity relationship study for phenylsulfonyl carboxylates using CoMFA and CoMSIA.

Molecular docking and 3D-QSAR study of pyranmycin derivatives against 16S rRNA A site